EUVIMEDEUVIMED entdecken
Open Access

Hydroxychloroquine Dose and Hospitalizations for Active Lupus

Jacquelyn Nestor iD, Hyon Choi, Christian Mancini, Baijun Zhou, Yuqing Zhang iD, Karen H Costenbader iD, April Jorge iD

Arthritis & Rheumatology · 2024

DOI: 10.1002/art.42924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2024. Verfasst von Jacquelyn Nestor und 6 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital, Harvard Medical School, Boston. Hauptthemen laut MEDLINE: Hydroxychloroquine, Lupus Erythematosus, Systemic, Hospitalization, Antirheumatic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We sought to determine the impact of hydroxychloroquine (HCQ) dose on the risk of hospitalizations for systemic lupus erythematosus (SLE).

Methods

We conducted a case‐crossover study within an academic health system, including patients with SLE who used HCQ and had ≥1 hospitalization for active SLE between January 2011 and December 2021. Case periods ended in hospitalization for SLE, whereas control periods did not. The exposures were the average weight‐based HCQ dose, categorized as ≤5 or >5 mg/kg/day, and non–weight‐based HCQ dose, categorized as 5 mg/kg/day) and non–weight‐based dose (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxychloroquineLupus Erythematosus, SystemicHospitalizationAntirheumatic AgentsHumansFemaleMaleAdultMiddle AgedCross-Over StudiesDose-Response Relationship, DrugCase-Control Studies

Substanzen

HydroxychloroquineAntirheumatic Agents

Autor:innen und Institutionen

  • Massachusetts General Hospital, Harvard Medical School, Boston.
  • Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

ORCID-Profile: Jacquelyn Nestor, Yuqing Zhang, Karen H Costenbader, April Jorge

Förderung

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • NIAMS NIH HHS

Zitieren

APA

Nestor, J., Choi, H., Mancini, C., Zhou, B., Zhang, Y., Costenbader, K. H., & Jorge, A. (2024). Hydroxychloroquine Dose and Hospitalizations for Active Lupus. Arthritis & Rheumatology. https://doi.org/10.1002/art.42924

Vancouver

Nestor J, Choi H, Mancini C, Zhou B, Zhang Y, Costenbader KH, et al. Hydroxychloroquine Dose and Hospitalizations for Active Lupus. Arthritis & Rheumatology. 2024. doi:10.1002/art.42924

BibTeX
@article{Nestor2024,
  author = {Nestor, Jacquelyn and Choi, Hyon and Mancini, Christian and Zhou, Baijun and Zhang, Yuqing and Costenbader, Karen H and Jorge, April},
  title = {Hydroxychloroquine Dose and Hospitalizations for Active Lupus},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  doi = {10.1002/art.42924}
}
Kostenlos starten →